JP Morgan analyst Jeffrey Zekauskas downgrades Dow (NYSE:DOW) from Overweight to Neutral.
Wegovy, Ozempic Could Save 139,400 Lives In US Each Year; Novo Nordisk Heart Attack Research Reveals New Benefits
So-called “miracle” weight-loss drugs like Wegovy, Ozempic and Mounjaro just reached a new milestone. Danish pharmaceutical giant Novo…